| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |